These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 7447407

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.
    Thauvin C, Eliopoulos GM, Willey S, Wennersten C, Moellering RC.
    Antimicrob Agents Chemother; 1987 Feb; 31(2):139-43. PubMed ID: 3105445
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacies of mezlocillin and ampicillin alone or in combination with gentamicin in the treatment of Streptococcus faecalis endocarditis in rabbits.
    Fass RJ, Wright CA.
    Antimicrob Agents Chemother; 1984 Apr; 25(4):408-10. PubMed ID: 6428306
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC, Grayson ML, Eliopoulos GM, Bayer AS.
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antimicrobial activity of gentamicin in experimental enterococcal endocarditis.
    Sullam PM, Täuber MG, Hackbarth CJ, Sande MA.
    Antimicrob Agents Chemother; 1985 Feb; 27(2):224-6. PubMed ID: 3920960
    [Abstract] [Full Text] [Related]

  • 8. Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis.
    Grayson ML, Thauvin-Eliopoulos C, Eliopoulos GM, Yao JD, DeAngelis DV, Walton L, Woolley JL, Moellering RC.
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1792-4. PubMed ID: 2126691
    [Abstract] [Full Text] [Related]

  • 9. Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.
    Hellinger WC, Rouse MS, Rabadan PM, Henry NK, Steckelberg JM, Wilson WR.
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1272-5. PubMed ID: 1416826
    [Abstract] [Full Text] [Related]

  • 10. Ampicillin remains inadequate therapy for enterococcal endocarditis.
    Feldman MD, Lewis DD, Stouffer GA, Sarembock IJ.
    South Med J; 1991 Feb; 84(2):284. PubMed ID: 1899297
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
    Lavoie SR, Wong ES, Coudron PE, Williams DS, Markowitz SM.
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
    López P, Gavaldà J, Martin MT, Almirante B, Gomis X, Azuaje C, Borrell N, Pou L, Falcó V, Pigrau C, Pahissa A.
    Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
    [Abstract] [Full Text] [Related]

  • 14. Imipenem therapy of experimental Staphylococcus aureus and Streptococcus faecalis endocarditis.
    Scheld WM, Keeley JM.
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():65-78. PubMed ID: 6421794
    [Abstract] [Full Text] [Related]

  • 15. [A case of enterococcal infectious endocarditis treated by ampicillin].
    Chassagnon C, Viallier J, Patricot LM, Chazalette JP.
    Lyon Med; 1968 Jan 07; 219(1):23-30. PubMed ID: 5664946
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.
    Bayer AS, Tu J.
    Antimicrob Agents Chemother; 1990 Jun 07; 34(6):1068-74. PubMed ID: 2118323
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy of experimental streptococcal endocarditis. VI. Prevention of enterococcal endocarditis.
    Durack DT, Starkebaum MK, Petersdorf RG.
    J Lab Clin Med; 1977 Jul 07; 90(1):171-9. PubMed ID: 406336
    [No Abstract] [Full Text] [Related]

  • 19. Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci.
    Auckenthaler R, Wilson WR, Wright AJ, Washington JA, Durack DT, Geraci JE.
    Antimicrob Agents Chemother; 1982 Sep 07; 22(3):448-52. PubMed ID: 6958215
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.